Johnson & Johnson Announces Submission of Application to the European Medicines Agency (EMA) for use of its COVID-19 Vaccine as a Booster Dose
- EMEA Innovative Medicine
- Johnson & Johnson Announces Submission of Application to the European Medicines Agency (EMA) for use of its COVID-19 Vaccine as a Booster Dose
Johnson & Johnson Announces Submission of Application to the European Medicines Agency (EMA) for use of its COVID-19 Vaccine as a Booster Dose
-
X (Twitter) -
LinkedIn -
Pinterest -
Copy link